13F Pro Quality Score

69.0/100

Rank #386 of 2,879 stocksTOP 25%

View Financials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

65.5/100

Profitability

72.1/100

Balance Sheet

94.0/100

Earnings Quality

65.9/100

Free Cash Flow

69.7/100

Institutional Flow

55.9/100

Revenue Scale

48.1/100

Dilution Risk

72.1/100

CRVL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CORVEL CORP (CRVL), a Financials sector company. 13F Pro's AI-powered ranking engine scores CRVL at 69.0/100 on a 32-signal composite quality model, placing it at rank #386 of 2,879 stocks — the top 25% of the AI-ranked universe. CRVL scores in the top quartile across balance sheet strength (94.0). Based on the latest XBRL financial filings (Q4 2026), CORVEL CORP reports quarterly revenue of $248.5M, net income of $31.0M, an operating margin of 16.0%. Top institutional holders of CRVL by reported 13-F value include BlackRock,, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. CRVL trades on the Nasdaq exchange and files with the SEC under CIK 874866. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRVL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CORVEL CORP directly from SEC EDGAR. CORVEL CORP's 13F Pro composite quality score has ranged between 8 and 72 since 2021, currently 69.0 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about CORVEL CORP

Quirks, history, and lore behind CRVL — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. managed care company · listed on Nasdaq · headquartered in Texas · serves the workers' compensation market.
  • 2
    The Numbers
    Annual revenue in the range of roughly $700 million · a small-cap with a surprisingly loyal institutional following and steadily expanding profit margins.
  • 3
    The History
    Founded in the late 1980s, it carved out a niche helping employers and insurers manage the cost and complexity of workplace injury claims long before that was fashionable.
  • 4
    The Secret
    Its secret weapon is a proprietary cost-containment platform that connects medical providers, payers, and injured workers — think managed care meets claims software.
  • 5
    The Lore
    Despite flying well under the radar, the company has delivered decades of consistent earnings growth and almost never needs to raise outside capital — a quiet compounder adored by patient investors.
  • 6
    The Giveaway
    If a worker gets hurt on the job, this Fort Worth-based specialist may be quietly coordinating their medical network, bill review, and case management before they even know what hit them — literally.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving CRVL's Business? Latest 10-K Breakdown

15/15 datapoints verified

AI-extracted from CORVEL CORP's 10-K filed 2026-05-22 — FY2026 (fiscal year ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

CorVel's FY2026 revenue grew 7% to $959M, with network solutions surging 15% driven by higher-margin enhanced bill review services.

Biggest Revenue Drivers

Total revenue: $959M+7% YoY

Patient Management Services$597M+3% YoY

Increase primarily from higher revenue from TPA and related services

Network Solutions Services$362M+15% YoY

Growth with existing customers expanding use of enhanced bill review programs services resulting in higher revenue per bill

Largest Expense Items

Cost of revenues$726M+6% YoY

Increase primarily due to 7% revenue growth; network solutions contributed higher-margin revenue offsetting costs

General and administrative$90M+1% YoY

Flat relative to revenue growth; historically maintained between 9% and 10% of revenues

Margins: Gross profit margin improved to 24.3% in FY2026 from 23.4% in FY2025, driven by higher-margin network solutions revenue mix and 7% revenue growth. Operating leverage also improved, with income before tax rising 18.5% while general and administrative expenses increased only 0.9%.

Watch Items from the Filing

  • Declining workers' compensation claims volume: occupational injuries fell to 2.34M in 2024 vs. 2.69M in 2019; Company offset via market share gains, but sustained declines could materially harm results.
  • Two customers account for 10%+ of accounts receivable as of March 31, 2026; no customer represents 10%+ of revenue, but concentration risk exists in collections.
  • Significant capitalized software development: $49.6M net as of March 31, 2026 (vs. $42.8M prior year); future impairment or obsolescence could impact asset values and earnings.
  • Company faces inflation pressures on labor (wages, benefits) and employee scarcity in nursing/healthcare roles; if unable to pass costs to customers, profitability could decline materially.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q4 2026

$248.5M

Net Income

Q4 2026

$31.0M

Free Cash Flow

Q4 2026

$20.3M

Operating Margin

Q4 2026

16.0%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+7.0% YoY
$958.5MFY 2026
FY21 $552.6MFY23 $718.6MFY25 $895.6MFY26 $958.5M

Net Income

+16.0% YoY
$110.3MFY 2026
FY21 $46.4MFY23 $66.4MFY25 $95.2MFY26 $110.3M

EPS (Diluted)

+16.9% YoY
$2.14FY 2026
FY21 $0.85FY23 $0.42FY25 $1.83FY26 $2.14

Total Assets

+17.8% YoY
$643.0MFY 2026
FY21 $424.8MFY23 $393.9MFY25 $546.0MFY26 $643.0M

Op. Cash Flow

+22.2% YoY
$155.6MFY 2026
FY21 $94.4MFY23 $82.3MFY25 $127.3MFY26 $155.6M

AI Insight: CRVL Ratio Trends

Profitability and returns collapsed in Q1 2026, with OpMargin and ROIC hitting multi-year lows despite strong recovery in 2025.

OpMargin plunged to 9.4% in Q1 2025, then recovered to 15.0% in Q2–Q3 2025 before declining to 13.7% in Q4 2025.

ROIC fell from 42.5% in Q2 2024 to 21.6% in Q1 2025, recovered to 41.2% in Q2 2025, then declined steadily to 34.3% by Q4 2025.

ROE dropped 5.1pp quarter-over-quarter from 30.8% (Q3 2025) to 25.7% (Q4 2025); ROA fell from 18.2% to 15.0% in same period.

Q1 2025 saw dramatic profitability compression (OpMargin –4.1pp, NPM –1.9pp, ROIC –18.9pp) — root cause and recurrence risk unclear.

Q4 2025 marks fourth consecutive quarter of ROIC decline from 41.2% peak; momentum deteriorating despite partial operational recovery.

Get alerted when CRVL's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CORVEL CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CRVL

Put CRVL on your watchlist

Track score changes the day CORVEL CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CRVL a good stock to buy?

13F Pro's AI-powered analysis of CORVEL CORP (CRVL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CRVL are available on the CRVL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CRVL?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CRVL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CORVEL CORP's investment landscape.